female infertility. female infertility-unspecifide
Conditions
Interventions
Intervention 1: in the intervention group patients receive HCG to trigger final oocytes with 24-hour delay. Intervention 2: In the control group receive HCG for routine final oocyte maturation on t
Treatment - Drugs
in the intervention group patients receive HCG to trigger final oocytes with 24-hour delay
In the control group receive HCG for routine final oocyte maturation on the same day
Sponsors
research and clinical center for infrtility
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: inclusion criteria:infertile patients under 40 years old who refereed to research and clinical center for infertility in yazd for IVF/ICSI exclusion criteria: age over 40 years
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of metaphase II oocytes. Timepoint: after intervention. Method of measurement: number.;Number of fertilized oocytes (2PN). Timepoint: after intervention. Method of measurement: number.;Number of embryo formation. Timepoint: after intervention. Method of measurement: number. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 14 days after transfer. Method of measurement: BHCG test.;Clinical pregnancy. Timepoint: 28 days after transfer. Method of measurement: transvaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Naghshineh
research and clinical center for infrtility
Outcome results
None listed